Response to androgen signaling (AS)-directed therapy after treatment with abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Post hoc analysis of study COU-AA-302.
Matthew R. Smith
Consultant or Advisory Role - Janssen
Research Funding - Janssen
Shannon Matheny
Employment or Leadership Position - Janssen Research & Development
Stock Ownership - Johnson & Johnson
Fred Saad
Consultant or Advisory Role - Astellas Pharma; Janssen
Honoraria - Astellas Pharma; Janssen
Research Funding - Astellas Pharma; Janssen
Dana E. Rathkopf
Research Funding - Johnson & Johnson
Peter F.A. Mulders
No relevant relationships to disclose
Johann Sebastian De Bono
Employment or Leadership Position - The Institute of Cancer Research
Consultant or Advisory Role - Astellas Pharma; Johnson & Johnson; Medivation
Honoraria - Astellas Pharma; Johnson & Johnson; Medivation
Eric Jay Small
No relevant relationships to disclose
Neal D. Shore
Consultant or Advisory Role - Algeta; Amgen; Astellas Pharma; Bavarian Nordic; Bayer; Dendreon; Ferring; Janssen; Millennium; Sanofi
Karim Fizazi
Consultant or Advisory Role - Janssen
Honoraria - Janssen
Thian San Kheoh
Employment or Leadership Position - Janssen Research & Development
Stock Ownership - Johnson & Johnson
Jinhui Li
Employment or Leadership Position - Janssen Research & Development
Mary Beth Todd
Employment or Leadership Position - Janssen
Stock Ownership - Johnson & Johnson
Thomas W. Griffin
Employment or Leadership Position - Janssen Research & Development
Stock Ownership - Johnson & Johnson
Margaret K. Yu
Employment or Leadership Position - Janssen Research & Development
Stock Ownership - Janssen Research & Development
Charles J. Ryan
Honoraria - Janssen